Cardiovascular Events in Hypertensive Hemodialysed Patients: Aliskiren Versus Amlodipine. A Randomized, Double-blind Study.

Trial Profile

Cardiovascular Events in Hypertensive Hemodialysed Patients: Aliskiren Versus Amlodipine. A Randomized, Double-blind Study.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Aliskiren (Primary) ; Amlodipine
  • Indications Cardiovascular disorders; Hypertension
  • Focus Therapeutic Use
  • Acronyms AL-AM dial
  • Most Recent Events

    • 09 Jul 2012 Planned End Date changed from 1 Jan 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 16 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top